The Third People's Hospital of Chengdu is the lead sponsor of 6 current clinical trials in our China register. 3 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Persistent Atrial Fibrillation.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity
NCT06720766 · ClinicalTrials.gov ↗ · Fatty Liver Disease
|
Observational | Recruiting | 2023-10 | China |
|
Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
NCT06652750 · ClinicalTrials.gov ↗ · Sick Sinus Syndrome, Atrioventricular Block, Second and Third Degree, Heart Failure
|
Not applicable | Recruiting | 2024-11 | China |
|
FIH Study of PFLotus in Persistent Atrial Fibrillation
NCT07301190 · ClinicalTrials.gov ↗ · Persistent Atrial Fibrillation
|
Not applicable | Recruiting | 2025-06 | China |
|
PRIor Myocardial Infarction Identification on Electrocardiogram
NCT06811194 · ClinicalTrials.gov ↗ · Prior Myocardial Infarction
|
Observational | By invitation | 2025-02 | China |
|
Using a Novel Balloon-shaped Large-Focal Pulsed Field Ablation Catheter in Persistent Atrial Fibrillation
NCT07294742 · ClinicalTrials.gov ↗ · Persistent Atrial Fibrillation
|
Not applicable | Active, closed | 2024-11 | China |
|
FIH of PFBalloon for PVI
NCT07320976 · ClinicalTrials.gov ↗ · Paroxysmal Atrial Fibrillation
|
Not applicable | Active, closed | 2024-07 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 6 | 3 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Boston Scientific Corporation | 4 |
| Medtronic Cardiac Ablation Solutions | 3 |
| Xu Liu | 2 |
Sponsors with the most current trials registered for this condition.
The Third People's Hospital of Chengdu is the lead sponsor of 6 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.